Edelman Joseph's Form 4 filing
Acrivon Therapeutics, Inc. (ACRV) · filed Apr 29, 2025
- Accession no.
- 0001062993-25-008214
- Filed
- Apr 29, 2025, 7:26 PM ET
- Trade date
- Apr 25-29, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.74M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edelman JosephCIK 0001164426 | 10% Owner |
| Perceptive Advisors LLCCIK 0001224962 | 10% Owner |
| Perceptive Life Sciences Master Fund LtdCIK 0001249675 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 25, 2025 | Common Stock | SSaleDisposed | −1,054,669 | $1.95 | −$2,056,604.55 | 4,306,189 | Indirect | |
| Apr 28, 2025 | Common Stock | SSaleDisposed | −215,283 | $1.56 | −$335,841.48 | 4,090,906 | Indirect | |
| Apr 29, 2025 | Common Stock | SSaleDisposed | −250,000 | $1.41 | −$352,500 | 3,840,906 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.